Tubulin polymerization inhibitor

DRUG CLASS:

Tubulin polymerization inhibitor

News alerts, weekly reports and conference planners

Related drugs:

No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	vincristine liposomal Sensitive: A1 - Approval vincristine liposomal Sensitive : A1	vincristine liposomal Sensitive: A1 - Approval vincristine liposomal Sensitive : A1
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline cisplatin + cyclophosphamide + vincristine Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline cisplatin + vincristine + lomustine Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Salivary Gland Cancer	No biomarker	Salivary Gland Cancer	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	vincristine + prednisone Sensitive: A2 - Guideline vincristine + prednisone Sensitive : A2	vincristine + prednisone Sensitive: A2 - Guideline vincristine + prednisone Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive : A2	vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive: A2 - Guideline vincristine + dexamethasone + mitoxantrone + pegaspargase Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA2 mutation	Triple Negative Breast Cancer	BRCA2 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA1 mutation	Triple Negative Breast Cancer	BRCA1 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2	doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + etoposide IV + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	vincristine + dactinomycin Sensitive: A2 - Guideline vincristine + dactinomycin Sensitive : A2	vincristine + dactinomycin Sensitive: A2 - Guideline vincristine + dactinomycin Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	irinotecan + vincristine Sensitive: A2 - Guideline irinotecan + vincristine Sensitive : A2	irinotecan + vincristine Sensitive: A2 - Guideline irinotecan + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + ifosfamide + vincristine Sensitive : A2	doxorubicin hydrochloride + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + ifosfamide + vincristine Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive : A2	doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive: A2 - Guideline doxorubicin hydrochloride + cyclophosphamide + ifosfamide + vincristine Sensitive : A2
No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Kaposi Sarcoma	No biomarker	Kaposi Sarcoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Astrocytoma	No biomarker	Astrocytoma	lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive: A2 - Guideline lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive : A2	lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive: A2 - Guideline lomustine + procarbazine hydrochloride + vincristine liposomal Sensitive : A2
No biomarker	Ewing Sarcoma	No biomarker	Ewing Sarcoma	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2	temozolomide + irinotecan + vincristine Sensitive: A2 - Guideline temozolomide + irinotecan + vincristine Sensitive : A2
No biomarker	Malignant Pleural Mesothelioma	No biomarker	Malignant Pleural Mesothelioma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	vincristine + prednisone + daunorubicin + pegaspargase Sensitive: A2 - Guideline vincristine + prednisone + daunorubicin + pegaspargase Sensitive : A2	vincristine + prednisone + daunorubicin + pegaspargase Sensitive: A2 - Guideline vincristine + prednisone + daunorubicin + pegaspargase Sensitive : A2
No biomarker	T Acute Lymphoblastic Leukemia	No biomarker	T Acute Lymphoblastic Leukemia	vincristine + prednisone + daunorubicin + pegaspargase + nelarabine Sensitive: A2 - Guideline vincristine + prednisone + daunorubicin + pegaspargase + nelarabine Sensitive : A2	vincristine + prednisone + daunorubicin + pegaspargase + nelarabine Sensitive: A2 - Guideline vincristine + prednisone + daunorubicin + pegaspargase + nelarabine Sensitive : A2

Tubulin polymerization inhibitor

Tubulin polymerization inhibitor

Associations(54)

Associations
(54)